These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds. Abdul Rahman SM; Bhatti JS; Thareja S; Monga V Eur J Med Chem; 2023 Nov; 259():115699. PubMed ID: 37542987 [TBL] [Abstract][Full Text] [Related]
23. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies. de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of Novel 1,2,3-Triazole Derivatives of Isocoumarins and 3,4-Dihydroisocoumarin with Potential Antiplasmodial Activity da Silva Santos L; de Carvalho MFL; de Souza Pinto AC; da Fonseca AL; Dias Lopes JC; de Pilla Varotti F; de Freitas RP; Alves RB Med Chem; 2021; 17(8):820-833. PubMed ID: 32484772 [TBL] [Abstract][Full Text] [Related]
25. 7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies. Pereira GR; Brandão GC; Arantes LM; de Oliveira HA; de Paula RC; do Nascimento MF; dos Santos FM; da Rocha RK; Lopes JC; de Oliveira AB Eur J Med Chem; 2014 Feb; 73():295-309. PubMed ID: 24469080 [TBL] [Abstract][Full Text] [Related]
26. The Plasmodium falciparum eIK1 kinase (PfeIK1) is central for melatonin synchronization in the human malaria parasite. Melatotosil blocks melatonin action on parasite cell cycle. Dias BKM; Nakabashi M; Alves MRR; Portella DP; Dos Santos BM; Costa da Silva Almeida F; Ribeiro RY; Schuck DC; Jordão AK; Garcia CRS J Pineal Res; 2020 Oct; 69(3):e12685. PubMed ID: 32702775 [TBL] [Abstract][Full Text] [Related]
28. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays. Okokon JE; Antia BS; Mohanakrishnan D; Sahal D Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254 [TBL] [Abstract][Full Text] [Related]
29. Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against Plasmodium falciparum parasites. Sugawara A; Tanaka T; Hirose T; Ishiyama A; Iwatsuki M; Takahashi Y; Otoguro K; Ōmura S; Sunazuka T Bioorg Med Chem Lett; 2013 Apr; 23(8):2302-5. PubMed ID: 23499502 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antimalarial activities of a diverse set of triazole-containing furamidine analogues. Berger O; Kaniti A; van Ba CT; Vial H; Ward SA; Biagini GA; Bray PG; O'Neill PM ChemMedChem; 2011 Nov; 6(11):2094-108. PubMed ID: 21905228 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities. Kant R; Kumar D; Agarwal D; Gupta RD; Tilak R; Awasthi SK; Agarwal A Eur J Med Chem; 2016 May; 113():34-49. PubMed ID: 26922227 [TBL] [Abstract][Full Text] [Related]
32. Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum. Schuck DC; Jordão AK; Nakabashi M; Cunha AC; Ferreira VF; Garcia CR Eur J Med Chem; 2014 May; 78():375-82. PubMed ID: 24699367 [TBL] [Abstract][Full Text] [Related]
33. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum. Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112 [TBL] [Abstract][Full Text] [Related]
34. Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors. Silveira FF; de Souza JO; Hoelz LVB; Campos VR; Jabor VAP; Aguiar ACC; Nonato MC; Albuquerque MG; Guido RVC; Boechat N; Pinheiro LCS Eur J Med Chem; 2021 Jan; 209():112941. PubMed ID: 33158577 [TBL] [Abstract][Full Text] [Related]
35. In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles. Joshi MC; Wicht KJ; Taylor D; Hunter R; Smith PJ; Egan TJ Eur J Med Chem; 2013 Nov; 69():338-47. PubMed ID: 24077524 [TBL] [Abstract][Full Text] [Related]
36. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum. Penna-Coutinho J; Aguiar AC; Krettli/ AU Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180279. PubMed ID: 30540020 [TBL] [Abstract][Full Text] [Related]
37. Antimalarial and Gupta S; Saini M; Joshi N; Shafi S; Najmi AK; Singh S J Biomol Struct Dyn; 2023 Nov; 41(19):9462-9475. PubMed ID: 36351236 [TBL] [Abstract][Full Text] [Related]
38. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box. Tiwari NK; Reynolds PJ; Calderón AI Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496 [TBL] [Abstract][Full Text] [Related]
39. Triazole hybrid compounds: A new frontier in malaria treatment. Ravindar L; Hasbullah SA; Rakesh KP; Hassan NI Eur J Med Chem; 2023 Nov; 259():115694. PubMed ID: 37556947 [TBL] [Abstract][Full Text] [Related]
40. Novel series of 1,2,4-trioxane derivatives as antimalarial agents. Rudrapal M; Chetia D; Singh V J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]